Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Trillo MA et al. | 2013 | intact cell/cell culture, NB69 cells (neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 10–100 µT |
Tonini R et al. | 2001 | intact cell/cell culture, NG108-15 cells (the cells result from the fusion of N18TG-2 mouse neuroblastoma cells with C6BU-1 rat glioma cells) | magnetic field, 50/60 Hz | 60–360 µT |
Soydas T et al. | 2024 | intact cell/cell culture, NIH/3T3 aged mouse fibroblasts | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Lee HJ et al. | 2012 | intact cell/cell culture, NIH3T3 cells (mouse fibroblasts), normal and transfected with a c-Myc-containing vector or with an empty vetor | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.01–1 mT |
Morabito C et al. | 2010 | intact cell/cell culture, PC-12 cells | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
McFarlane EH et al. | 2000 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 4.35–15.8 µT |
Jung IS et al. | 2014 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Schimmelpfeng J et al. | 2005 | intact cell/cell culture, PC-12 cells/rat | magnetic field, 50/60 Hz | 100 µT |
Tekam CKS et al. | 2025 | intact cell/cell culture, RFP (red fluorescent protein)-L929 mouse fibroblast cells, animal, rat/ Wistar | magnetic field, 50/60 Hz, signals/pulses | - |
Wang Z et al. | 2024 | intact cell/cell culture, RSC96 cells, animal, rat/Sprague Dawley | 50/60 Hz, magnetic field, signals/pulses, also other exposures without EMF, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.